Results 71 to 80 of about 39,833 (142)

Disease-specific epigenetic deregulation of enhancers, transposons, and polycomb targets in acute promyelocytic leukemia

Genome Medicine
Background Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML), characterized by a fusion between the PML and RARA genes and by a block in the myeloid maturation at the promyelocytic stage.
Xiangfu Zhong, Lina Cordeddu, Angelica Gamboa-Cedeno, Sofia Bengtzén, Karl Ekwall, Andreas Lennartsson, Sören Lehmann   +6 more
doaj   +1 more source

Erratum to “Development and Validation of a LC/MS/MS Method for the Determination of Duloxetine in Human Plasma and Its Application to Pharmacokinetic Study”

Journal of Chemistry, 2013
D. Chandrapal Reddy, A. T. Bapuji, V. Suryanarayana Rao, V. Himabindu, D. Rama Raju, Syed Syedba, H. L. V. Ravikiran   +6 more
doaj   +1 more source

Letter from the Organising Secretary of the APL to T. Moran [PDF]

, 1939
Typescript letter dated 17 April 1939, to T.
Anti-Partition League, APL, Anti-Partition League   +1 more
core  

Improved Process for the Preparation of Naloxegol Oxalate, an Opiod Receptor Antagonist

ACS Omega, 2023
Siva Rama Kasibabu Velugula, Nimesh Chandra Misra, Suresh Chapala, Sunil Kumar Reddy Aaramadaka, Ramadas Chavakula, Paul Douglas Sanasi   +5 more
doaj   +1 more source

AN APL MACHINE. [PDF]

, 1970
openaire   +2 more sources

Minutes of Stamford Hill Branch of APL meeting, 12 April 1939. [PDF]

Manuscript minutes of Stamford Hill APL Branch. Second meeting, held on 12 April (probably 1939).
Anti-Partition League, APL, Anti-Partition League   +1 more
core  

APL '98: new gems from old roots

, 1998
The landscape of computing is continually changing. New achievements bring new possibilities to users and pose new challenges to both practitioners and theoreticians.
BELLINI, francesco
core  

C010 | INVESTIGATING DISTINCT FEATURES OF PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) REQUIRING TREATMENT ASSOCIATED WITH ANTIPHOSPHOLIPID ANTIBODIES: A SUB-ANALYSIS OF THE ITALIAN ITP REGISTRY (GIMEMA ITP0918)

Haematologica
Introduction. The clinical significance of positive antiphospholipid antibodies (aPL) in patients with primary immune thrombocytopenia (pITP) remains uncertain. To address this gap, we have compared the clinical characteristics of pITP patients with and
B. Clerici, G.M. Podda, L. Ghiotto, A. Barone, V. De Stefano, E. Rossi, S. Mangone, N. Vianelli, M. Venturi, V. Carrai, S. D'angelo, A. Borchiellini, F. Valeri, M. Carpenedo, E.M. Bertinato, C. Santoro, E. Baldacci, U. Consoli, V. Innao, F. Zaja, E. Lucchini, A. Poloni, D. Lame, S. Siragusa, M. Napolitano, F. Pane, C. Giordano, E. Rivolti, K. Codeluppi, V. Pavone, S. Sibilla, D. Lazzarotto, C. Bosi, W. Barcellini, B. Fattizzo, P. Gresele, A.M. Mezzasoma, M. Crugnola, F. Di Raimondo, G. Giuffrida, U. Markovic, F. Paoloni, A. Rughini, E. Crea, P. Fazi, F. Rodeghiero, G. Carli   +46 more
doaj  

Some of the next articles are maybe not open access.

Related searches:

The Design of APL

IBM Journal of Research and Development, 1973
This paper discusses the development of APL, emphasizing and illustrating the principles underlying its design. The principle of simplicity appears most strongly in the minimization of rules governing the behavior of APL objects, while the principle of practicality is served by the design process itself, which relies heavily on experimentation.
Adin D. Falkoff, Kenneth E. Iverson
openaire   +2 more sources

Using APL to monitor APL

Proceedings of the eighth international conference on APL - APL '76, 1976
APL, both in the language and in system libraries, provides aids to the programmer which permit him to monitor and analyze the execution of his defined functions. If he couples the use of error messages with stop and trace control, he can converge upon function definitions which correctly perform his algorithms.
Anton G. Wellbrock, John W. Mizzi, Richard D. Moore   +2 more
openaire   +2 more sources